Personalized medicine has revolutionized cancer treatment by tailoring therapies to individual genetic profiles. This book explores the pharmacological strategies underpinning personalized cancer therapy, including targeted agents, immunotherapies, and combination treatments. It discusses the role of biomarkers in treatment selection, the development of resistance, and the optimization of therapeutic regimens. Designed for oncologists, pharmacologists, and biomedical researchers, the book highlights cutting-edge research and clinical applications that enhance the precision and effectiveness of cancer treatments.
Sophia Kelley is a leading dermatologist specializing in the pharmacology of personalized cancer therapy, focusing on tailored treatments for skin cancers such as melanoma and squamous cell carcinoma. Her research explores the use of targeted therapies, immunotherapies, and combination treatments based on individual patient profiles, including genetic and molecular markers. Sophia has authored numerous studies on optimizing pharmacological strategies to enhance treatment efficacy and minimize side effects in personalized cancer care. She has developed comprehensive personalized cancer therapy protocols that improve treatment outcomes for dermatological malignancies.